BLOOD CLOTTING ACCELERANT MARKET ANALYSIS

Market News

Key Developments-

1. In 2019, Grifols, S.A. and Johnson & Johnson announced that it received approval from the U.S. Food Drug and Administration to market VISTASEAL. Vistaseal is a fibrin sealant used to manage surgical bleeding.
2. In 2019, Octapharma AG, announced that the human fibrinogen concentrate FIBRYGA received approval for use in treatment of acquired fibrinogen deficiency (AFD) in 15 European countries
3. In 2017, Ethicon, a subsidiary of Johnson & Johnson, announced that it received approval from the U.S. Food Drug and Administration (FDA) Surgicel powder adsorbate hemostat. Surgicel powder is used in surgical procedures to control the flow of blood.